Advertisement
Letter| Volume 10, ISSUE 5, P997-1000, September 2017

Sustained remission in patients with treatment-resistant depression receiving vagal nerve stimulation: A case series

      Highlights

      • VNS in treatment-resistant depression can help sustain near-permanent remission.
      • VNS was very well tolerated by all patients without any major adverse effects.
      • VNS demonstrates resilience: remission regained after battery/device failure.
      • These patients have heavy family histories of depressive illness and/or alcoholism.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Rush A.J.
        • Trivedi M.H.
        • Wisniewski S.R.
        • Nierenberg A.A.
        • Stewart J.W.
        • Warden D.
        • et al.
        Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
        Am J Psychiatry. 2006; 163: 1905-1917
        • Corey-Lisle P.K.
        • Birnbaum H.G.
        • Greenberg P.E.
        • Marynchenko M.B.
        • Claxton A.J.
        Identification of a claims data “signature” and economic consequences for treatment-resistant depression.
        J Clin Psychiatry. 2002; 63: 717-726
        • Sackeim H.A.
        • Brannan S.K.
        • Rush A.J.
        • George M.S.
        • Marangell L.B.
        • Allen J.
        Durability of antidepressant response to vagus nerve stimulation (VNS).
        Int J Neuropsychopharmacol. 2007; 10: 817-826
        • Nahas Z.
        • Marangell L.B.
        • Husain M.M.
        • Rush A.J.
        • Sackeim H.A.
        • Lisanby S.H.
        • et al.
        Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes.
        J Clin Psychiatry. 2005; 66: 1097-1104
        • Conway C.R.
        • George M.S.
        • Sackeim H.A.
        Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough.
        JAMA Psychiatry. 2017; 74: 9-10
        • Aaronson S.T.
        • Sears P.
        • Ruvuna F.
        • Bunker M.
        • Conway C.R.
        • Dougherty D.D.
        • et al.
        A 5-year observational study of patients with treatment-resistant depression treated with Vagus Nerve stimulation or treatment as usual: comparison of response, remission, and suicidality.
        Am J Psychiatry. 2017 March 31; (appiajp201716010034, http://dx.doi.org/10.1176/appi.ajp.2017.16010034)
        • Rush A.J.
        • Sackeim H.A.
        • Marangell L.B.
        • George M.S.
        • Brannan S.K.
        • Davis S.M.
        • et al.
        Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
        Biol Psychiatry. 2005; 58: 355-363
        • Aaronson S.T.
        • Carpenter L.L.
        • Conway C.R.
        • Reimherr F.W.
        • Lisanby S.H.
        • Schwartz T.L.
        • et al.
        Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.
        Brain Stimul. 2013; 6: 631-640
        • Niciu M.J.
        • Luckenbaugh D.A.
        • Ionescu D.F.
        • Guevara S.
        • Machado-Vieira R.
        • Richards E.M.
        • et al.
        Clinical predictors of ketamine response in treatment-resistant major depression.
        J Clin Psychiatry. 2014; 75: e417-e423
        • Conway C.R.
        • Chibnall J.T.
        • Tait R.C.
        Vagus nerve stimulation for depression: a case of a broken lead, depression relapse, revision surgery, and restoration of patient response.
        Brain Stimul. 2008; 1: 227-228